News
 
AstraZeneca Pharma drops as company skips dividend on poor financials
Capital Market/11:15,May 22, 2013
AstraZeneca Pharma India fell 2.31% to Rs 774.50 at 11:04 IST on BSE after the company skipped equity dividend for the year ended 31 March 2013.
list AstraZeneca Pharma India - Board to consider Dividend
list Pfizer gains after Q4 earnings
list Pfizer Appoints Director
list Pfizer Recommends Dividend
list Pfizer net profit rises 20.91% in the March 2013 quarter

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
Economic Events
list Foreign Buying Japan Bonds (Yen)
list Japan Buying Foreign Bonds (Yen)
Results
list Larsen & Toubro | Zee Entertainmen | Thermax
IPO
list Issue Closing : Just Dial
 
Skip Navigation Links.

Aventis Pharma to announce financial results
Capital Market/ 16:47 , Jul 06, 2012

Board meeting on 25 July 2012

The board meeting of Aventis Pharma will be held on 25 July 2012 to consider and approve the unaudited financial results for the quarter and half year ended 30 June 2012. The board will also consider declaration of interim dividend for the current financial year ending on 31 December 2012.
 



Rate This Article Rate 1 Rate 2 Rate 3 Rate 4 Rate 5

Recent News Videos